Skip to content

A study to see the effect of Chavydi ghana vati in kaphaj prameha ( Diabetes)

Randomised controlled comparative clinical study to evaluate efficacy of Chavyadi ghana vati in sthul kaphaj prameha WSR to type two Diabetes mellitus - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108758
Enrollment
70
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr Krutika Purushottam Ingle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having age group 30 to 70 years Patients of any gender, religion & socio economic status Patients having sign symptoms of prameha with BMI 25 to 30 HBa1c 6.5 to 8.5 %

Exclusion criteria

Exclusion criteria: IDDM patients Patients having HBa1c less than 6.5% and more than 8.5% pregnancy ,unconscious patients Juvenile diabetes,Acromegaly,cushings syndrome,pancreatic disorder

Design outcomes

Primary

MeasureTime frame
Reduction in HB A1c level Reduction in symptoms of sthul kaphaj pramehaTimepoint: 90 days

Secondary

MeasureTime frame
Reduction in sthaulya Reduction in kapha dominant featuresTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Krutika Purushottam Ingle

Ayurved Seva Sangh Ayurved Mahavidyala, Ganeshwadi ,Panchavati ,Nashik- 03

sawale.kumud@gmail.com9923102717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026